Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (XT) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sales | 60.52 | 52.03 | 13.72 | 20.51 | 12.87 |
| Operating profit | 1.48 | 3.84 | -7.87 | -2.04 | -4.01 |
| Interest | 0.92 | 1.78 | 1.09 | 0.75 | 0.89 |
| Gross profit | 0.56 | 2.15 | -8.93 | -2.78 | -4.88 |
| EPS (Rs) | -0.43 | 2.87 | -5.67 | -3.19 | -4.44 |
Annual
results in details
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Other income | - | 0.09 | 0.03 | 0.01 | 0.02 |
| Stock adjustment | 4.55 | -6.39 | 0.59 | -1.67 | 0.42 |
| Raw material | 42.67 | 43.02 | 14.99 | 17.75 | 9.51 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.33 | 0.73 | 0.61 | 0.80 | 0.91 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 11.50 | 10.82 | 5.40 | 5.67 | 6.04 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.59 | 1.20 | 1.00 | 1.02 | 0.94 |
| Taxation | 0.12 | 0.21 | -0.15 | -0.24 | 0.05 |
| Net profit / loss | -0.61 | 2.93 | -5.79 | -3.25 | -4.53 |
| Extra ordinary item | 0.55 | 2.19 | 3.99 | 0.30 | 1.34 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 14.20 | 10.20 | 10.20 | 10.20 | 10.20 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 2.44 | 7.39 | -57.36 | -9.96 | -31.15 |
| GPM (%) | .92 | 4.13 | -64.93 | -13.53 | -37.88 |
| NPM (%) | -1.01 | 5.62 | -42.10 | -15.86 | -35.14 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis